ArticleVirchows Archiv : an international journal of pathology2012
Subgross breast pathology in the twenty-first century.
Article in Virchows Archiv : an international journal of pathology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subgross studies on breast morphology in cleared thick sections are informative, but lengthy protocols could clash with diagnostic timescales and interfere with immunohistochemistry (IHC) or molecular analysis. We sought to speed up staining and tissue clearing to improve compatibility with diagnostic needs without detriment to histology or other assays. Thick sections (2-3 mm) of normal human breast tissue and whole mouse mammary glands were stained with alum-carmine, aceto-carmine, Harris's haematoxylin, cresyl violet, neutral red, thionin, 4',6-diamidino-2-phenylindole (DAPI), ethidium bromide (EB), or propidium iodide (PI) and cleared in xylene (refractive index ν = 1.50), benzyl alcohol/benzyl benzoate (BABB; ν = 1.59), xylene-BABB (X-BABB), thiodiglycol (2,2'-thiodiethanol, ν = 1.52) or anethole (ν = 1.56). Tissue was then paraffin embedded for IHC for ER, PR, E-cadherin, CD31 or cytokeratin 7. Haematoxylin and alum-carmine are excellent non-fluorescent subgross stains giving strong nuclear staining and minimal background. DAPI and EB permeate thick sections poorly but PI penetrates well, with a high signal-to-noise ratio after clearing in BABB or X-BABB. Other clearing agents were less effective, including thiodiglycol. Anethole's unpleasant odour precluded further evaluation. All evaluated clearing agents preserved comparable immunoreactivity for all markers. PI is a promising stain for subgross breast studies, compatible with BABB clearing. The hope that the water-miscible thioalcohol, thiodiglycol, might accelerate tissue clearing was not realised. There is scope for further streamlining to make subgross techniques more acceptable in combined research/diagnostic settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.